Ann: ResApp Receives CE Mark for ResAppDx-EU, page-105

I'm in this for the long-term so if I was to see this from a short-term point of view I would say at least 30 cents putting us back into that trading range before the failed smart cough C1 results. We should get there a lot quicker when our German partner commences the pilot study and if we see positive data from the double blind sleep apnea trials... that should be enough to get us into this trading range... from there if we receive FDA clearance we should hit all-time highs.. and obviously if any deals are signed up beforehand where we will end up is anyone's guess, obviously won't be anywhere near this level...

Cheers

Red bar